The Long Run
Summary
The Long Run is hosted by Luke Timmerman covering Nimbus Therapeutics, Biotech Business Models, Capital Efficiency, and Asset Monetization. Notable guests include Abbas Kazimi (CEO, Nimbus Therapeutics), and Martin Burke (Professor of Chemistry and Director of the Molecule Maker Lab at the University of Illinois at Urbana-Champaign). Episodes span from Apr 2026 to Apr 2026.
Martin Burke's pioneering 'block chemistry' enables the rapid, automated synthesis of small molecules by using a standardized, iterative process, significantly reducing a major bottleneck in drug d...
Nimbus Therapeutics has pioneered a capital-efficient biotech model, using a lean team, virtual R&D, and a unique LLC/C-corp structure to develop and monetize high-value assets. The company's strat...